N-acetylcysteine modulates the cytotoxic effects of paclitaxel

Chemotherapy

Volumn 57, Issue 4, 2011, Pages 298-304

  Lyle, Patricia Anne ^a,b   Mitsopoulos, Panagiotis ^a,b   Suntres, Zacharias E ^a,b  

^a NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

A549 cells; Antioxidants; Apoptosis; Caspases; N acetylcysteine; Paclitaxel; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC ALKALOID; ANTIOXIDANT; CASPASE 10; CASPASE 3; CASPASE 7; PACLITAXEL; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL CYCLE ARREST; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

ACETYLCYSTEINE; ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; CASPASE 10; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; PACLITAXEL; REACTIVE OXYGEN SPECIES;

EID: 79960540778     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000329510     Document Type: Article

References (39)

1. Rodríguez-Antona C: Pharmacogenomics of paclitaxel. Pharmacogenomics 2010; 11: 621-623.
2. Steed H, Sawyer MB: Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel. Pharmacogenomics 2007; 8: 803-815. (Pubitemid 47288979)
3. Zhao J, Kim JE, Reed E, Li QQ: Molecular mechanism of antitumor activity of taxanes in lung cancer (review). Int J Oncol 2005; 27: 247-256.
4. Ganansia-Leymarie V, Bischoff P, Bergerat JP, Holl V: Signal transduction pathways of taxanes-induced apoptosis. Curr Med Chem Anticancer Agents 2003; 3: 291-306. (Pubitemid 36758303)
5. André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D: Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett 2002; 532: 256-260. (Pubitemid 35375900)
6. Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG: Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 2009; 28: 3551-3562.
7. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR: Taxol induces caspase-10-dependent apoptosis. J Biol Chem 2004; 279: 51057-51067. (Pubitemid 40017847)
8. Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FAE, Giaccone G: Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCIH460. Clin Cancer Res 2002; 8: 596-606. (Pubitemid 34193982)
9. Hadzic T, Aykin-Burns N, Zhu Y, Coleman MC, Leick K, Jacobson GM, Spitz DR: Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress. Free Radic Biol Med 2010; 48: 1024-1033.
10. Jang HJ, Hwang S, Cho KY, Kim do K, Chay KO, Kim JK: Taxol induces oxidative neuronal cell death by enhancing the activity of NADPH oxidase in mouse cortical cultures. Neurosci Lett 2008; 443: 17-22.
11. Rhee SG: Cell signaling: H2O2, a necessary evil for cell signaling. Science 2006; 312: 1882-1883. (Pubitemid 43993698)
12. England K, Cotter TG: Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep 2005; 10: 237-245. (Pubitemid 44111130)
13. Circu ML, Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749-762.
14. Trachootham D, Lu W, Ogasawara MA, Valle NR-D, Huang P: Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343-1374.
15. Hans Konrad B, Jürgen F: Antioxidants in cancer therapy: is there a rationale to recommend antioxidants during cancer therapy? Biofactors 2003; 17: 229-240.
16. Conklin KA: Cancer chemotherapy and antioxidants. J Nutr 2004; 134: 3201S-3204S. (Pubitemid 39470116)
17. Ladas E, Kelly KM: The antioxidant debate. Explore (NY) 2010; 6: 75-85.
18. Muralikrishnan G, Amanullah S, Basha MI, Boopalan S, Vijayakumar S, Shakeel F: Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients. Chemotherapy 2010; 56: 298-302.
19. Labriola D, Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999; 13: 1003-1008, discussion 1008, 1011-1012.
20. DAndrea GM: Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005; 55: 319-321.
21. De Larco JE, Park CA, Dronava H, Furcht LT: Paradoxical roles for antioxidants in tumor prevention and eradication. Cancer Biol Ther 2010; 9: 362-370.
22. Sadowska AM, Manuel-y-Keenoy B, De Backer WA: Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: Discordant in vitro and in vivo doseeffects: a review. Pulm Pharmacol Ther 2007; 20: 9-22. (Pubitemid 44648802)
23. Arakawa M, Ito Y: N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 2007; 6: 308-314. (Pubitemid 350179062)
24. Alexandre J, Batteux F, Nicco C, Chéreau C, Laurent A, Guillevin L, Weill B, Goldwasser F: Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006; 119: 41-48.
25. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007; 67: 3512-3517. (Pubitemid 46762129)
26. Huizing M, Keung A, Rosing H, van der Kuij V, ten Bokkel Huinink W, Mandjes I, Dubbelman A, Pinedo H, Beijnen J: Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinumpretreated ovarian cancer patients. J Clin Oncol 1993; 11: 2127-2135. (Pubitemid 23332248)
27. Fukui M, Yamabe N, Zhu BT: Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 2010; 46: 1882-1891.
28. Martin KR: Targeting apoptosis with dietary bioactive agents. Exp Biol Med 2006; 231: 117-129. (Pubitemid 43213448)
29. Groeger G, Quiney C, Cotter TG: Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009; 11: 2655-2671.
30. Wang LW, Shi YL, Wang N, Gou BD, Zhang TL, Wang K: Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells. Chemotherapy 2009; 55: 460-467.
31. Huang Y, Sheikh MS, Fornace AJ Jr, Holbrook NJ: Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Oncogene 1999; 18: 3431-3439. (Pubitemid 29317338)
32. Ueda S, Nakamura H, Masutani H, Sasada T, Yonehara S, Takabayashi A, Yamaoka Y, Yodoi J: Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J Immunol 1998; 161: 6689-6695. (Pubitemid 28562211)
33. Hampton MB, Stamenkovic I, Winterbourn CC: Interaction with substrate sensitises caspase-to inactivation by hydrogen peroxide. FEBS Lett 2002; 517: 229-232. (Pubitemid 34327665)
34. Janssen-Heininger YM, Aesif SW, van der Velden J, Guala AS, Reiss JN, Roberson EC, Budd RC, Reynaert NL, Anathy V: Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease. Ann NY Acad Sci 2010; 1203: 23-28.
35. Wang YF, Chen CY, Chung SF, Chiou YH, Lo HR: Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol 2004; 54: 322-330.
36. Brown DI, Griendling KK: Nox proteins in signal transduction. Free Radic Biol Med 2009; 47: 1239-1253.
37. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Görlach A: NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 2006; 8: 1473-1484. (Pubitemid 44726324)
38. Simone CB, 2nd, Simone NL, Simone V, Simone CB: Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 2007; 13: 22-28. (Pubitemid 46110631)
39. Moss RW: Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther 2006; 5: 63-82. (Pubitemid 43263024)